A detailed history of First Long Island Investors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, First Long Island Investors, LLC holds 4,105 shares of MRK stock, worth $407,133. This represents 0.04% of its overall portfolio holdings.

Number of Shares
4,105
Previous 5,253 21.85%
Holding current value
$407,133
Previous $650,000 28.31%
% of portfolio
0.04%
Previous 0.06%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$111.15 - $128.97 $127,600 - $148,057
-1,148 Reduced 21.85%
4,105 $466,000
Q2 2024

Aug 07, 2024

BUY
$123.8 - $132.96 $419,434 - $450,468
3,388 Added 181.66%
5,253 $650,000
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $186,835 - $203,322
1,865 New
1,865 $203,000
Q2 2023

Aug 08, 2023

BUY
$108.61 - $118.38 $202,557 - $220,778
1,865 New
1,865 $215,000
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $163,075 - $209,085
1,865 New
1,865 $206,000
Q3 2021

Nov 01, 2021

SELL
$71.68 - $78.83 $206,295 - $226,872
-2,878 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$70.42 - $80.13 $16,689 - $18,990
-237 Reduced 7.61%
2,878 $223,000
Q1 2020

May 11, 2020

SELL
$63.36 - $87.82 $1,267 - $1,756
-20 Reduced 0.64%
3,115 $240,000
Q4 2019

Feb 14, 2020

BUY
$77.58 - $87.54 $1,551 - $1,750
20 Added 0.64%
3,135 $285,000
Q1 2019

May 14, 2019

SELL
$69.58 - $79.36 $3,826 - $4,364
-55 Reduced 1.74%
3,115 $259,000
Q3 2018

Nov 02, 2018

BUY
$57.69 - $67.84 $182,877 - $215,052
3,170 New
3,170 $225,000
Q1 2018

May 04, 2018

SELL
$50.96 - $59.23 $220,300 - $256,051
-4,323 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $28,161 - $30,302
480 Added 12.49%
4,323 $277,000
Q2 2017

Aug 14, 2017

BUY
N/A
3,843
3,843 $0

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track First Long Island Investors, LLC Portfolio

Follow First Long Island Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Long Island Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Long Island Investors, LLC with notifications on news.